MS Speaks

HERE FOR 19 YEARS--for people with an interest in multiple sclerosis

Pages: [1]

		Subject / Started by	Replies / Views	Last post
		Tyruko--first biosimilar to treat MS--now available Tyruko--first biosimilar to treat MS--now available agate · November 17, 2025, 03:25:53 pm From Managed Health Care Executive (November 17, 2025)--"Tyruko, the first biosimilar to treat multiple sclerosis, is now availa... 0 Replies · 23 Views Started by agate	0 Replies 23 Views	November 17, 2025, 03:25:53 pm by agate
		Possible adverse side effects found after switch from Tysabri to Tyruko Possible adverse side effects found after switch from Tysabri to Tyruko agate · February 24, 2025, 08:34:08 pm From The Guardian (February 24, 2025)--"MS patients suffer side effects after NHS England switches to cheaper drug":https://www.... 0 Replies · 90 Views Started by agate	0 Replies 90 Views	February 24, 2025, 08:34:08 pm by agate
		FDA-approved Tyruko (natalizumab-sztn) FDA-approved Tyruko (natalizumab-sztn) agate · August 26, 2024, 08:47:13 pm Tyruko is a Tysabri biosimilar. It is administered as a 1-hour IV infusion, every 4 weeks. https://www.tyruko.com/ 1 Replies · 200 Views Started by agate	1 Replies 200 Views	August 26, 2024, 08:59:24 pm by agate

Pages: [1]

Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)

Locked Topic
Sticky Topic
Poll

Create your own free forum at CreateAForum.com | Report Abuse